Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
09/30/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
Ingresos
594
593
573
551
555
513
Crecimiento de los Ingresos (YoY)
-8%
3%
4%
-1%
8%
32%
Costo de los ingresos
329
323
318
312
299
269
Utilidad bruta
265
270
254
239
255
243
Venta, General y Administración
248
261
262
263
252
231
Investigación y Desarrollo
33
30
31
32
27
22
Gastos de Operación
282
291
294
295
279
253
Otras Ingresos (Gastos) No Operativos
0
0
0
-2
0
-16
Ingreso antes de impuestos
-3
-7
-19
-20
-9
-49
Gasto por Impuesto a la Renta
-32
-31
5
-11
1
-20
Ingreso Neto
-57
-55
-164
-14
2,132
110
Crecimiento de la Utilidad Neta
-65%
-66%
1,071%
-101%
1,838%
72%
Acciones en Circulación (Diluidas)
45.92
45.74
53.17
66.25
74.9
74.2
Cambio de Acciones (YoY)
1%
-14%
-20%
-12%
1%
1%
EPS (Diluido)
-1.25
-1.21
-3.1
-0.22
28.47
1.49
Crecimiento de EPS
-65%
-61%
1,309%
-101%
1,811%
69%
Flujo de efectivo libre
30
38
12
-33
-543
97
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
44.61%
45.53%
44.32%
43.37%
45.94%
47.36%
Margen de operación
-2.69%
-3.54%
-6.8%
-10.16%
-4.32%
-1.94%
Margen de beneficio
-9.59%
-9.27%
-28.62%
-2.54%
384.14%
21.44%
Margen de flujo de caja libre
5.05%
6.4%
2.09%
-5.98%
-97.83%
18.9%
EBITDA
40
40
51
29
29
55
Margen de EBITDA
6.73%
6.74%
8.9%
5.26%
5.22%
10.72%
D&A para EBITDA
56
61
90
85
53
65
EBIT
-16
-21
-39
-56
-24
-10
Margen de EBIT
-2.69%
-3.54%
-6.8%
-10.16%
-4.32%
-1.94%
Tasa de Impuesto Efectiva
1,066.66%
442.85%
-26.31%
55%
-11.11%
40.81%
Estadísticas clave
Cierre Anterior
$28.12
Precio de apertura
$29.51
Rango del día
$27.99 - $29.51
Rango de 52 semanas
$23.91 - $48.22
Volumen
800.2K
Volumen promedio
671.0K
EPS (TTM)
-1.26
Rendimiento de dividendos
--
Cap. de mercado
$1.3B
¿Qué es AZTA?
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.